WEST VALLEY CITY, Utah, May 6, 2024 /PRNewswire/ — Scientia Vascular, a leader in neurovascular innovation, is thrilled to announce the FDA clearance of two uniquely engineered catheters: the Plato 17—a DMSO-compatible microcatheter—and the Socrates 38, an aspiration catheter engineered for ischemic stroke. This marks a significant milestone for Scientia’s ascent in the neurovascular market, showcasing the company’s commitment to pioneering medical advancements.

Logo of company Scientia Vascular

The introduction of Plato® 17 microcatheter and Socrates® 38 aspiration catheter epitomizes Scientia’s ethos of continuous innovation. Renowned for disrupting the industry with microfabricated guidewires, Scientia has applied the same groundbreaking technologies, design principles, and precision machinery to revolutionize catheter manufacturing. This distinct approach exemplifies the company’s dedication to pushing the boundaries of medical technology.